Pomalidomide Capsule
Product Images NDC 0781-2354

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pomalidomide (NDC 0781-2354). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Pomalidomide 01)

Chemical structure of pomalidomide, the active ingredient in Pomalidomide capsules by Sandoz Inc. The diagram shows the molecular arrangement of pomalidomide's ring systems and functional groups.*

FDA Label Image

Figure-1 (Pomalidomide 02)

A Kaplan-Meier progression-free survival curve comparing two treatments: HD-DEX (solid line) and POM+LD-DEX (dashed line). The vertical axis shows the proportion of subjects, and the horizontal axis shows time in months. The chart includes a statistical summary of the comparison between the two groups and a table showing the number of subjects at risk over time.*

FDA Label Image

Figure-2 (Pomalidomide 03)

A Kaplan-Meier survival curve comparing overall survival between two groups: HD-DEX and POM+LD-DEX, over a 24-month period. The Y-axis shows the proportion of subjects surviving, and the X-axis shows time in months. There is a table below indicating the number of subjects at risk at various time points for each group, along with statistical data including logrank p-value, hazard ratio, confidence intervals, median survival times, and event counts.*

FDA Label Image

1mg-21ct-label (Pomalidomide 04)

Label for Pomalidomide Capsules 1 mg oral dose, containing 21 capsules. The label includes a warning about potential for human birth defects and instructions for pharmacists to dispense a Medication Guide. It lists storage conditions, manufacturer Aizant Drug Research Solutions for Sandoz Inc., and states the product is from India.*

FDA Label Image

2mg-21ct-label (Pomalidomide 05)

Label for Pomalidomide Capsules, 2 mg strength, oral dosage form by Sandoz Inc. The label includes a warning about potential human birth defects, instructions for pharmacists to dispense the enclosed Medication Guide, and storage directions to keep the product between 20°C to 25°C with allowed excursions. The package contains 21 capsules. Manufactured by Aizant Drug Research Solutions Pvt. Ltd. for Sandoz Inc., Princeton, NJ.*

FDA Label Image

3mg-21ct-label (Pomalidomide 06)

Label for Pomalidomide Capsules 3 mg, oral capsules containing 21 capsules per package. The label includes a warning about potential human birth defects and storage instructions to keep at 20°C to 25°C. Manufactured for Sandoz Inc. by Aizant Drug Research Solutions Pvt. Ltd., product of India, with NDC 0781-2366-27.*

FDA Label Image

4mg-21ct-label (Pomalidomide 07)

Label for Pomalidomide Capsules 4 mg by Sandoz Inc. The label includes a warning about potential human birth defects and instructions to dispense the enclosed medication guide. It specifies a package size of 21 capsules. Storage instructions indicate to keep at 20°C to 25°C with permitted excursions and to keep out of reach of children. The label also notes the product is manufactured in India for Sandoz Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.